Vitamin Shoppe Inc. (NYSE:VSI) saw unusually-high trading volume on Friday . Approximately 576,531 shares traded hands during trading, an increase of 151% from the previous session’s volume of 229,264 shares.The stock last traded at $29.26 and had previously closed at $29.51.

Several brokerages have commented on VSI. Goldman Sachs Group Inc. lowered shares of Vitamin Shoppe to a “hold” rating in a research report on Saturday, April 30th. Macquarie reaffirmed a “neutral” rating and issued a $40.00 price objective on shares of Vitamin Shoppe in a research report on Thursday, May 5th. Sterne Agee CRT reaffirmed a “neutral” rating on shares of Vitamin Shoppe in a research report on Monday, May 16th. Piper Jaffray Cos. reaffirmed a “neutral” rating and issued a $30.00 price objective on shares of Vitamin Shoppe in a research report on Friday, April 15th. Finally, Zacks Investment Research raised shares of Vitamin Shoppe from a “hold” rating to a “buy” rating and set a $32.00 price objective on the stock in a research report on Tuesday, May 24th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and two have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $32.82.

The company has a market capitalization of $697.30 million and a price-to-earnings ratio of 16.68. The company has a 50-day moving average price of $30.81 and a 200-day moving average price of $29.90.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, May 4th. The company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.02. The company had revenue of $336.80 million for the quarter, compared to analysts’ expectations of $339.76 million. The business’s revenue was up .0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.63 EPS. Equities analysts expect that Vitamin Shoppe Inc. will post $2.32 earnings per share for the current year.

In related news, Director Guillermo Marmol purchased 1,000 shares of the company’s stock in a transaction dated Tuesday, May 31st. The shares were purchased at an average price of $30.23 per share, with a total value of $30,230.00. Following the acquisition, the director now directly owns 1,470 shares in the company, valued at approximately $44,438.10. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Several institutional investors have modified their holdings of the company. Employees Retirement System of Texas acquired a new position in shares of Vitamin Shoppe during the fourth quarter valued at $1,275,000. Rhumbline Advisers boosted its position in shares of Vitamin Shoppe by 4.3% in the fourth quarter. Rhumbline Advisers now owns 45,118 shares of the company’s stock valued at $1,475,000 after buying an additional 1,855 shares during the period. Gabelli Funds LLC boosted its position in shares of Vitamin Shoppe by 15.2% in the fourth quarter. Gabelli Funds LLC now owns 53,040 shares of the company’s stock valued at $1,734,000 after buying an additional 7,000 shares during the period. California State Teachers Retirement System boosted its position in shares of Vitamin Shoppe by 1.6% in the fourth quarter. California State Teachers Retirement System now owns 55,107 shares of the company’s stock valued at $1,802,000 after buying an additional 885 shares during the period. Finally, State of Wisconsin Investment Board boosted its position in shares of Vitamin Shoppe by 0.8% in the fourth quarter. State of Wisconsin Investment Board now owns 159,102 shares of the company’s stock valued at $5,203,000 after buying an additional 1,229 shares during the period.

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.